This absence of IGF-1 stimulation is critical for appetite neutrality because IGF-1 has known effects on hypothalamic neuropeptide expression, including alterations to neuropeptide Y (NPY) and agouti-related peptide (AgRP), both potent appetite stimulators
The activation of G i -type G-proteins leads to the inhibition of adenylate cycles and, thus, reduced production of cAMP, resulting in the same effects as those initiated by activation of the insulin receptor
No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance
They can help you choose the right approach, monitor your progress, and watch for any potential issues
349 g5226
AOD9604 peptide has shown benefits in studies of heart disease, bone /cartilage repair, and metabolic syndrome